THERAPEUTIC AGAINST corneal-conjunctival impairment

摘要

1. A therapeutic agent for corneal conjunctival disorders containing eprosartan or its salt as an active ingredient. ! 2. The therapeutic agent against corneal conjunctival disorders according to claim 1, wherein the corneal conjunctival disorder is dry eye syndrome, corneal ulcer, keratitis, conjunctivitis, puncture superficial keratitis, corneal epithelial disorder, conjunctival epithelial disorder, keratoconjunctival conjunctival dry or filamentous keratitis. ! 3. The therapeutic agent against corneal conjunctival disorders according to claim 1 or 2, wherein the dosage form of the drug is eye drops or an ophthalmic ointment. ! 4. A method of treating corneal conjunctival disorders, comprising administering to the patient a therapeutically effective amount of eprosartan or a salt thereof. ! 5. A method for the treatment of corneal conjunctival disorders according to claim 4, wherein the corneal conjunctival disorder is dry eye syndrome, corneal ulcer, keratitis, conjunctivitis, pitting superficial keratitis, corneal epithelial disorders, conjunctival epithelial disorders, dry keratoconjunctivitis, or upper keratoconjunctivitis, or filamentous keratitis. ! 6. A method of treating corneal conjunctival disorders according to claim 4 or 5, wherein the form of administration of eprosartan or its salt is eye drops or ophthalmic ointments. ! 7. The use of eprosartan or its salt for the manufacture of a therapeutic agent against corneal conjunctival disorder. ! 8. The use according to claim 7, where the corneal conjunctival disorder is a dry syndrome